Media covering ADITEC’s activities or issues related to it, can contact us for information and interview possibilities.
ADITEC in the media
ADITEC regularly shows up in a diverse range of media productions. Here is a selection of media productions related to ADITEC:
In 2017 ADITEC has been mentioned in a series of articles and news, including:
- Tutti i vaccini del terzo millennio– La Repubblica Salute (Nov 2017)
- Agenda della settimana– Aditec Annual Meeting – il Sole 24 ore Toscana
- Conoscere per giudicare. Vaccini, Rappuoli: “Dobbiamo educare genitori, bambini e pediatri” – Agenzia Impress.it
- Vaccini personalizzati per età: Siena fa da apripista – MeteoWeb – it
- Nuove tecnologie per i vaccini del futuro presentati all’Università di Siena i risultati del progetto europeo di ricerca.
Università di Siena, Ufficio Stampa –Ilcittadinoonline.it
Antennaradioesse.it (with audio interviews)
Radio_Siena_Tv_-_Facebook (facebook page)
- Presentazione dei risultati del progetto ADITEC – Advanced Immunization Technologies – Siena – Conferenza Stampa
- Nuove tecnologie per i vaccini del futuro. Si è concluso il progetto europeo ADITEC– advanced immunization technologies -UnisiInforma
- Rappuoli: “I no-vax? Non averli educati un nostro fallimento” – Corriere Fiorentino
Rappuoli: “No vax? Non mi preoccupano”(video)- Agenziaimpress - Le nuove tecnologie per i vaccini del futuro. Ecco i sei anni di lavoro del progetto ADITEC – Corriere di Siena
- Meeting conclusivo del progetto di ricerca Aditec – Corriere di Siena
- Con l’alta tecnologia dei vaccini Siena torna leader in Europa– La Nazione Siena
- I vaccini del futuro all’Università di Siena– La Nazione Siena
- Meeting conclusivo del progetto di ricerca europeo ADITEC – ResearchItaly, il portale della ricerca Italiana
- A Siena i vaccini del futuro – STAMPToscana
- ADITEC – ADVANCED IMMUNIZATION TECHNOLOGIES – ANNUAL MEETING 2017 -Unisinforma
- Nuove tecnologie per i vaccini del futuro presentati all’Università di Siena i risultati del progetto europeo di ricerca ADITEC– Twitter by Corrado Zunino
- Donata Medaglini, docente dell’Università di Siena e coordinatrice scientifica del progetto ADITEC (video interview) – Siena News
- Presentati all’Università di Siena i risultati del progetto europeo di ricerca Aditec- Advanced Immunization Technologies. Ne parla il Rettore Francesco Frati (video interview) – Siena News
- Public service broadcasting on Aditec (video) – Canale 3
- Public service broadcasting on Aditec (video) – Radio Siena TV Notizie
ADITEC Press Release – 9th of November 2016 – was published in:
- ResearchItaly- The portal of Italian Research
ADITEC, the great European project on vaccines presented at the European Parliament - Gonews.it
ADITEC guida il progetto Ue sui vaccini: è una storia di successo - Institut Pasteur
The ADITEC Project on Advanced Immunization Technologies: an European Success Story - European Vaccine Initiative
ADITEC Annual Meeting - VisMederi – Analysis for Life Improvement
VisMederi is research partner in the ADITEC Project – 2016 Annual Meeting in Brussels and event at the European Parliament. - AfricaScienceNews
Project on Advanced Immunization Technologies: A success Story - Il Sole 24 Ore. Sanità 24.
Vaccini, il progetto Aditec presentato al Parlamento Ue
- Boon or burden: what has the EU ever done for science? Nature 16 June 2016
- Tuberculosi. Strade nuove per il vaccino. L’Espresso, 20 February 2014
- Sigmoid Pharma Completes Phase II trial of CyCol™ in more than 100 Ulcerative Colitis Patients and Raises €3 million, Business Wire, 17 May 2012, also on Bloomberg
- Joining forces for better vaccines, EMBO encounters, summer 2012
- Intercell AG : announces Q3 2011 results and provides an update on ongoing operations, 4-traders.com, 8 November 2011
Results 1st ADITEC press release
Italy
- Nove da Firenze: Parte il progetto ADITEC – Advanced Immunization Technologies
- Siena news: Sclavo Vaccines Association e Università di Siena insieme nel progetto ADITEC
- Il Cittadino: Sclavo Vaccines Association coordina il progetto Aditec
- Sanità in cifre: Vaccini, l’Iss partecipa al progetto europeo ADITEC per aumentarne sicurezza ed efficacia
- GuidaFormazione: Parte il progetto ADITEC- Advanced Immunization Technologies
- FAI Informazione: Vaccini, l’Iss partecipa al progetto europeo ADITEC per aumentarne sicurezza ed efficacia
- Weblog Antonio Caperna: Vaccini, progetto ADITEC: IRB di Bellinzona tra i partner di ricerca
- Controcampus: Università di Siena: parte il progetto ADITEC
- Antenna Radio Esse: Ricerca scientifica: Siena conferma il suo ruolo di protagonista
- Libero: Parte il progetto ADITEC – Advanced Immunization Technologies
- Siena Free: Al via il progetto ADITEC: Siena capitale mondiale dei vaccini
- Il Taggatore: IRB, EU invests €30 million to boost vaccine research
France
- Le quotidien du medecin: 30 millions pour la recherche vaccinale en Europe
Spain
- Emprendia: Nuevo proyecto europeo de investigación de nuevas vacunas
- Myether.net: Proyecto ADITEC
The Netherlands
- Krant van Flevoland: Vaccinonderzoek: EU investeert € 30 miljoen
- Nieuwsbank: EU boosts vaccine research with €30 mln
- Utrecht Science Park: EU investeert €30 miljoen in vaccinonderzoek
- Utrechtnieuws.nl: Universiteit Utrecht zoekt mee naar nieuwe generatie vaccins
- Nationale zorggids: Universiteit Utrecht zoekt mee naar nieuwe generatie vaccins
- Agrarisch Dagblad: EU investeert 30 miljoen in vaccin-onderzoek
- Dier en arts: EU investeert 30 miljoen in vaccin-onderzoek
- Medical Facts: Universiteit Utrecht zoekt mee naar nieuwe generatie vaccins
- Pharmasite.nl: EU investeert 30 miljoen euro in vaccinonderzoek
- Dutch Vaccines Group: EU investeert 30 miljoen euro in vaccinonderzoek
- Flevopost: EU investeert 30 miljoen euro in vaccinonderzoek
Austria
- FriedlNews: Intercell: EU Invests € 30m in Research Program
- Aktien forum: EU investiert EUR 30 Mio. in die Impfstoffforschung
- Analyst Award: EU investiert 30 Mio. Euro in Impfstoff-Forschung
- Oesterreich Journal: EU investiert EUR 30 Mio. in die Impfstoffforschung
- Die Presse: Impfstoffe haben die Medizin revolutioniert. Dennoch gibt es noch viele Lücken im immunologischen Wissen. Die EU startet daher nun ein riesiges Forschungsprojekt.
- Kronen Zeitung Tirol: Großes EU-Projekt: Innsbruck forscht mit
Switzerland
- Swiaabiotech.org: Pevion participates in €30 million EU vaccine research project
- Techno-science (linking to approx. 15 other websites): Vers des vaccins plus efficaces et tout aussi sûrs
- Tribune de Geneve: Nouveaux vaccins: un million d’euros pour des chercheurs genevois
- Association des Médecins du canton de Genève: Vers des vaccins taillés sur mesure
- MyScience: Vers des vaccins plus efficaces et tout aussi sûrs – Plus d’un million d’euros pour un projet genevois en vaccinologie
- Centre de Documentation en Santé Publique & InfoDoc Promotion de la Santé: Vers des vaccins taillés sur mesure : l’Europe lance un vaste programme de recherche
- 24 Heures: Nouveaux vaccins: un million d’euros pour des chercheurs genevois
- Le Matin : Nouveaux vaccins: un million d’euros pour des chercheurs genevois
- Le Temps : Vers des vaccins personnalisés (via login)
Scotland
- Compute Schotland: Immunisation in Europe, Spain and Canada
- Enterprise Europe Network: EUR 30 million in EU funding for new vaccines
Germany
- Boerse express.com: EU investiert 30 Mio. Euro in Impfstoff-Forschung
- Bionity.com: EU invests €30 million to boost vaccine research
- Life Sciences Germany The EU Boosts Vaccine Research with €30 Million”. Brussels.
Sweden
- Lifescience Stockholm Uppsala Xbrane Bioscience receives 4 million SEK
- Biotech Sweden EU satsar 265 miljoner på vaccinforskning
USA
- WUSA9.com: EC provides EUR 30M to international vaccine program
- Georgia research alliance: Emory Vaccine Center joins partnership to advance vaccine R&D worldwide
- The Emory Wheel: Joins Worldwide Vaccine Research
- DigitalJournal: IDRI Partners With Global Research Initiative ADITEC to Accelerate Human Vaccine Development
- News Online: IDRI joins ADITEC to accelerate human vaccine development
- Manufacturing chemist: IDRI joins ADITEC vaccine development project
Greece
Denmark
- Berlingske: Ny influenzavaccine kan virke i årevis
International
- InfoGrokPharma: Intercell to Begin EC Funded ADITEC Program
- Biocentury: EC provides EUR 30M to international vaccine program
- Stop TB Partnership: European Union invests 30 million Euros in new vaccine research programme
- Bioportfolio: EU invests €30 million to boost vaccine research
- TB Online: EU invests €30 million to boost vaccine research
- net: €30 million in EU funding to speed up the development of new vaccines
- 4-traders: Intercell AG : EU invests €30 million to boost vaccine research
Websites ADITEC partners
- Cordis Europe: EUR 30 million in EU funding for new vaccines
- European Commission, research and innovation: The EU boosts vaccine research with €30 Million
- IBA: Collaborative EU-project ADITEC
- IRB: EU invests €30 million to boost vaccine research, the IRB is one of the 42 grantees
- USI: La Commissione europea investe 30 milioni di euro per promuovere la ricerca sui vaccini: l’IRB è parte del programma (29.09.2011)
- University of Utrecht: EU invests €30 million to boost vaccine research
- EU investeert €30 miljoen in vaccinonderzoek
- Xbrane: EU invests €30 million to boost vaccine research
- Pevion: Pevion participates in €30 million EU vaccine research project
- TBVI: EU invests €30 million to boost vaccine research
- SSI: Forskere på Statens Serum Institut er centrale partnere i EU’s 250 millioner kroner store investering i vaccineforskning
- University of Geneva: Vers des vaccins plus efficaces et tout aussi sûrs – Plus d’un million d’euros pour un projet genevois en vaccinology
- Hopiteuax Universitaires de Geneve: Vers des vaccins plus efficaces et tout aussi sûrs
- Intercell : EU invests €30 million to boost vaccine research
- University of Gothenburg: 44 miljoner kronor till Göteborgs universitet från FAS
- Göteborgsforskare ska utveckla nästa generation vacciner
- Austrian Academy of Sciences: EU investiert EUR 30 Mio. in die Impfstoffforschung
- ISS: Vaccini, l’ISS partecipa al progetto europeo ADITEC per aumentarne sicurezza ed efficacia
- Vaccibody: EU invests €30 million to boost vaccine research
- BMI Oslo: Vaccibody partner in ADITEC
- Xbrane: EU invests €30 million to boost vaccine research
- Institut Pasteur: L’Union Européenne investit 30 millions d’euros pour renforcer la recherche vaccinale
- Emory: Emory Vaccine Center Partners with Global Initiative to Boost Vaccine Research and Development